
MDXG: Is MiMedx Group, Inc. Halal?
MiMedx Group, Inc.
$4.30
-2.93%
Market Cap: 640.5M
Compliance Status
Doubtful
Screened on Jul 20, 2026 · AAOIFI Standard 21
Good
Is MiMedx Group, Inc. (MDXG) halal? Doubtful. Based on AAOIFI screening, MiMedx Group, Inc. passes the business activity screen but has financial ratios approaching AAOIFI limits with a compliance score of 70/100 (Grade: B+).
Business activity
What the company sells is permissible.
Company debt
Well clear of the limitHow much the company borrows, compared to its total value. AAOIFI allows up to 30%.
What this means for you
You may own MDXG, with caution
Its numbers sit close to AAOIFI limits. Cautious investors may prefer alternatives or ask a scholar first.
Purify 1.1% of your income from MDXG
That is about $1.10 of every $100 you earn from it. Donate this share to charity.
Calculate my exact amountAbout MiMedx Group, Inc.
MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to treat human placental tissues, a method crucial for manufacturing allografts that preserve the natural biological characteristics and essential regulatory proteins of the original tissue. This exclusive and patented processing technique incorporates both aseptic procedures and a final sterilization step, ensuring product safety and efficacy. Among its offerings is EpiFix, a semi-permeable membrane designed to act as a protective barrier, effectively treating persistent wounds such as diabetic foot ulcers, venous leg ulcers, and pressure sores. Another key product is AmnioFix, a protective, semi-permeable allograft made from dehydrated human amnion/chorion membrane, utilized to aid post-surgical recovery. EpiCord and AmnioCord, both derived from dehydrated human umbilical cord, function as allografts that foster a protective healing environment and are applied in both advanced wound care and surgical recovery contexts. AMNIOBURN is also a semi-permeable protective allograft specifically developed for managing partial and full-thickness burn injuries. Its flagship product, mdHACM, is a micronized, powdered version of AMNIOFIX. These products predominantly find use in healthcare sectors like wound management, burn treatment, surgical procedures, and non-operative sports medicine. Additionally, the company supplies allografts for dental uses to other manufacturers on an original equipment manufacturer (OEM) basis. Distribution of its products primarily occurs within the United States, facilitated by its own sales teams, independent agents, and various independent distributors. MiMedx Group, Inc.'s main office is located in Marietta, Georgia.
Sector: Healthcare · Industry: Biotechnology
Why This Stock Is Doubtful
- Interest-bearing deposits are 25.9% of market cap, only 4.1 points below the 30% limit
Stocks are marked Doubtful when financial ratios pass but approach AAOIFI thresholds. Consider consulting a qualified scholar for a definitive ruling.
Shariah Compliance Status
Compliance History
Doubtfulnow
since Jun 2026
Not Halal
until the change above
Tracked since Jun 2026. Updates automatically on each re-screen.
More Healthcare Stocks
Track MDXG and 10,000+ stocks with AI insights
Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.
Frequently Asked Questions
Is MiMedx Group, Inc. (MDXG) halal to invest in?
Why did MiMedx Group, Inc. get a B+ compliance rating?
What could change MiMedx Group, Inc.'s Shariah verdict?
How often is MiMedx Group, Inc. re-screened for Shariah compliance?
Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.
Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.